Vaxxinity, University of Central Florida launch collaboration to advance medicines for use in space
疫苗IPO免疫疗法
Preview
来源: FierceBiotech
Vaxxinity and the University of Central Florida launch an effort to advance space medicine research and prevent bone and muscle density loss during long space flights.
Vaxxinity, an immunotherapeutic vaccine developer, is boldly going into partnership with the University of Central Florida to advance space medicine research.
The effort, which is being funded by a grant from the State of Florida, will focus on developing Vaxxinity’s immunotherapies to prevent and mitigate muscle and bone wasting, which are health challenges related to long-term spaceflight, the company said in a Jan. 18 release.
The research will include studies of the company’s active immunotherapies on undisclosed proteins implicated with bone and muscle growth through in vitro and in vivo experiments, as well as animal models established by the university. As part of the collaboration, Vaxxinity will provide materials including drug candidates derived from its platform to support the collaborative research.
“If humanity is to become a spacefaring species, solving fundamental problems related to space travel and living are table-stakes,” Lou Reese, executive chairman of Vaxxinity, said in the release. “Vaxxinity is all-in on developing and commercializing these solutions, and working with the State of Florida and UCF, collectively, we strive to promote both healthy aging and ensure humanity can become multi-planetary, brave low gravity exposure, and be of the stars.”
Vaxxinity, which is based in Cape Canaveral in Florida, raised $78 million in its 2021 IPO just months after coming together in a deal between COVAXX and United Neuroscience. At the time the company launched it touted its synthetic peptide vaccine platform as having the potential to enable a new class of medicines.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
靶点
-药物
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。